Clinical Trials Logo
  1. Home
  2. Early Lung Cancer
  3. NCT05802654

Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer — USBRT-1  

Stereotactic Body Radiotherapy Clinical Trial

Official title:
Clinical Study of Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer

Clinical Trial Summary

The goal of this prospective single-arm phase II study is to study the efficacy and safety of stereotactic body radiotherapy (SBRT) for early lung cancer. The main questions it aims to answer are: How effective is this regimen of SBRT for early lung cancer? How safe is this regimen of SBRT for early lung cancer?

Clinical Trial Description

The goal of this prospective single-arm phase II study is to study the efficacy and safety of stereotactic body radiotherapy (SBRT) for early lung cancer. This study intends to enroll 100 participants in 2 years. The participants enrolled will receive single fraction of ultra-high dose stereotactic body radiotherapy (SBRT) (30Gy/1F). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05802654
Study type Interventional
Source Peking University Third Hospital
Contact Hongqing Zhuang, M.D.
Phone +861082264910
Email hongqingzhuang@163.com
Status Not yet recruiting
Phase N/A
Start date June 2023
Completion date June 2028
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05919641 - LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT
Recruiting NCT05598060 - Preoperative Stereotactic Body Radiotherapy (SBRT) Followed by Hepatectomy for Centrally Located Hepatocellular Carcinoma: a Prospective, Single-center, Phase I Study N/A
Active, not recruiting NCT05101824 - Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease N/A
Completed NCT06408753 - Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT
Recruiting NCT03460925 - Improving REsectability in Pancreatic NEoplasms (IRENE) N/A
Not yet recruiting NCT05286320 - Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis. Phase 1/Phase 2
Recruiting NCT05430737 - A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer N/A
Recruiting NCT03609268 - Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma N/A
Recruiting NCT03609151 - Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma N/A
Not yet recruiting NCT05915481 - Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors Phase 1/Phase 2
Completed NCT01213758 - Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT N/A
Recruiting NCT03529708 - Stereotactic Body Radiotherapy Boost After Palliative Radiotherapy for Spinal Cord Compression N/A
Recruiting NCT04160143 - Post SBRT Pulmonary Metastasectomy (PSPM) Trial N/A
Active, not recruiting NCT05802641 - Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer
Not yet recruiting NCT05136768 - Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC) Phase 2
Recruiting NCT06167876 - Safety and Efficacy of Stereotactic Body Radiotherapy in the Treatment of Hypertrophic Obstructive Cardiomyopathy N/A
Recruiting NCT05615142 - Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC. Phase 1
Completed NCT06195254 - Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer
Completed NCT04966195 - Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombosis N/A
Recruiting NCT03750396 - Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer Phase 2